Facilitating Global Innovation & Partnering

Client Login

Press Releases

Technology Catalysts has been interviewed and/or featured in a number of published articles over the years. To view these articles and other TCI press releases, please select a document from the list below:

Robust Growth Predicted for Abuse Deterrent Formulations

May 01, 2015

Spurred by strong public interest, the FDA is actively reviewing guidance on the need for abuse deterrent formulations. The FDA is currently working on a case-by-case basis to determine whether or not opioid based formulations should only receive approval if they possess abuse deterrent properties.

Poorly Soluble and Poorly Permeable Drugs valued at $145 billion represent significant reformulation and market opportunities

July 01, 2014

Poor bioavailability is a major reason for compounds to fail in preclinical development. Technology Catalysts International (TCI) has compiled and analyzed technical and market information pertaining to the delivery of poorly water soluble or poorly permeable pharmaceutical compounds.

New Business Opportunities Identified in Rapidly Growing $38 Billion Medical and Functional Foods Markets

July 01, 2013

Consumer and scientific interest in the relationship between diet, health, and alternative medicines has created an increased demand for medical and modified functional foods. Sparked by rising interest in attaining wellness through diet, factors such as rapid advances in science and technology, increasing healthcare costs, changes in food labeling and claim regulations, and aging populations, have fueled the growth of both markets.

Orally Disintegrating Tablets and Thin Films Poised to See Strong Growth

April 01, 2013

Orally disintegrating tablets (ODTs) are coming into their own as mainstream pharmaceutical products. Oral thin films (OTFs) have also come into strong prominence with the launch of Suboxone® (buprenorphine and naloxone) thin films demonstrating a huge potential for thin films in prescription products.

Developments for patient-friendly delivery systems for the $150 billion biologics market

March 01, 2013

Emerging opportunities in drug device combinations to address the critical needs of the rapidly growing biologics market for patient friendly administration.

Cancer Vaccines Poised to Reach $3 Billion in Sales by 2015

April 01, 2011

Alternative Probiotic Applications Offer $2Billion+ Market Potential

March 01, 2011

Emerging opportunities in probiotics to address oral, women's, and additional digestive healthcare to greatly increase the market for probiotic strains.

Parenteral Depots Offer $8 Billion of Reformulation Opportunities and a Strong Competitive Edge in Crowded Pharmaceutical Space

February 01, 2011